Published in Med Res Rev on November 01, 2001
Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators. J Med Chem (2011) 0.86
Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha. Endocrinology (2009) 0.83
Molecular Basis of Steroid Action in the Prostate. Cellscience (2005) 0.83
Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens. J Androl (2005) 0.83
Binding mode of ecdysone agonists to the receptor: comparative modeling and docking studies. J Mol Model (2003) 0.77
Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status. Front Oncol (2016) 0.75
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
The bromodomain revisited. Trends Biochem Sci (1997) 2.95
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell (2000) 2.77
Yeast tRNA(Asp) recognition by its cognate class II aminoacyl-tRNA synthetase. Nature (1993) 2.57
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell (2000) 2.33
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63
Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy. J Pathol (1992) 1.41
The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci (1999) 1.33
The impact of protein characterization in structural proteomics. Acta Crystallogr D Biol Crystallogr (2006) 1.32
A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J (1997) 1.30
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J (2001) 1.27
Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J (1996) 1.22
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci U S A (2001) 1.20
Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem (2000) 1.16
Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem (2001) 1.15
Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif (2001) 1.14
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 1.12
Antagonism in the human mineralocorticoid receptor. EMBO J (1998) 1.08
The structure of cyclin H: common mode of kinase activation and specific features. EMBO J (1997) 1.08
Preliminary X-ray investigation of 70 S ribosome crystals from Thermus thermophilus. J Mol Biol (1989) 1.07
A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol (1997) 1.02
Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors. Breast Cancer Res (2000) 1.01
A role for a helical connector between two receptor binding sites of a long-chain peptide hormone. J Biol Chem (2000) 0.99
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Chem Biol (1999) 0.99
Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain. Br J Pharmacol (2007) 0.99
Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin Chim Acta (1993) 0.97
Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania. Int J Tuberc Lung Dis (2012) 0.96
Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor. Mol Cell Biol (1999) 0.95
Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain. Br J Pharmacol (2006) 0.95
Features that distinguish those who die from asthma from community controls with asthma. J Asthma (1998) 0.95
Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. J Mol Biol (2001) 0.92
Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol Cell Biol (1999) 0.91
Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data. J Med Chem (1998) 0.90
Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin Immunol Immunopathol (1985) 0.88
Crystallization and preliminary X-ray analysis of Escherichia coli methionyl-tRNA(fMet) formyltransferase. Proteins (1996) 0.86
Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid. Biochem Biophys Res Commun (1997) 0.85
Crystallization of Escherichia coli aspartyl-tRNA synthetase in its free state and in a complex with yeast tRNA(Asp). Acta Crystallogr D Biol Crystallogr (1996) 0.84
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res (1999) 0.83
HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul Pept (1998) 0.83
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors. Protein Expr Purif (1999) 0.82
Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. J Mol Endocrinol (1997) 0.81
Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol (2000) 0.81
A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones. Mol Pharmacol (2000) 0.81
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Mol Endocrinol (2000) 0.81
Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor. Protein Expr Purif (1995) 0.80
Amino acids specifying MHC class preference in TCR V alpha 2 regions. J Immunol (1999) 0.79
Investigation of the binding interactions of progesterone using muteins of the human progesterone receptor ligand binding domain designed on the basis of a three-dimensional protein model. Biochim Biophys Acta (1999) 0.78
Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity. Crit Rev Biochem Mol Biol (1998) 0.78
Gonadotropin-releasing hormone (GnRH) analogs: relationship between their structure, proteolytic inactivation and pharmacokinetics in rats. Regul Pept (1991) 0.77
Local TH1 and TH2 responses to parasitic infection in the intestine: regulation by IFN-gamma and IL-4. Vet Immunol Immunopathol (1996) 0.76
Peptide T and glucose metabolism in AIDS dementia complex. J Nucl Med (1996) 0.76
Pharmacology and clinical use of sex steroid hormone receptor modulators. Handb Exp Pharmacol (2012) 0.76
Interferon-mediated development of influenza virus resistance in hybrids between Mx gene-bearing and control mouse embryo fibroblasts. J Gen Virol (1983) 0.76
Improvement in AIDS patients on peptide T. Lancet (1989) 0.76
A continuously monitored colorimetric method for detection of Mycobacterium tuberculosis complex in sputum. Int J Tuberc Lung Dis (2013) 0.75
Disposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats. Drug Metab Dispos (1993) 0.75
Comparison of odour emission rates measured from various sources using two sampling devices. Bioresour Technol (2008) 0.75
Influence of continuous levels of fentanyl in rats on the mu-opioid receptor in the central nervous system. Pharmacol Biochem Behav (1997) 0.75
Digital subtraction indocyanine green angiography of occult choroidal neovascularization. Ophthalmology (1998) 0.75
Substance P: elimination from the circulation of the rat after intravenous injection. Pharmazie (1982) 0.75
Increased pulmonary flow velocities in oversized homografts in patients after the Ross procedure. Eur J Cardiothorac Surg (1997) 0.75
Gonadotropin-releasing hormone (GnRH) pharmacokinetics: peptide hormone pharmacokinetics needs clarification. Life Sci (1988) 0.75